Anthony W. Fox
Plus aucun poste en cours
Profil
Anthony W.
Fox worked as a Director at Symphony Allegro, Inc., Vice President-Drug Development at Cypros Pharmaceutical Corp., Chief Medical Officer at Conatus Pharmaceuticals, Inc., and Principal at Glaxo, Inc. He also served as President at EBD Group, Inc. Fox received his undergraduate degree in 1977 and his doctorate in 1988 from the University of London.
Anciens postes connus de Anthony W. Fox
| Sociétés | Poste | Fin |
|---|---|---|
| Glaxo, Inc. | Corporate Officer/Principal | - |
EBD Group, Inc.
 EBD Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Informa Plc, EBD Group, Inc. operates as a partnering company for the life science industry. The company is based in Carlsbad, CA. EBD Group was acquired by Informa Switzerland Ltd. on June 07, 2013. | President | - |
| Cypros Pharmaceutical Corp. | Corporate Officer/Principal | - |
| HISTOGEN INC. | Directeur Technique/Scientifique/R&D | - |
Symphony Allegro, Inc.
 Symphony Allegro, Inc. Pharmaceuticals: MajorHealth Technology Symphony Allegro, Inc. manufactures biopharmaceutical drugs. It develops clinical trials for the treatment of schizophrenia, bipolar, migraine, and panic attack disorders. The company was founded in 2006 and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | - |
Formation de Anthony W. Fox
| University of London | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Symphony Allegro, Inc.
Symphony Allegro, Inc. Pharmaceuticals: MajorHealth Technology Symphony Allegro, Inc. manufactures biopharmaceutical drugs. It develops clinical trials for the treatment of schizophrenia, bipolar, migraine, and panic attack disorders. The company was founded in 2006 and is headquartered in Rockville, MD. | Health Technology |
| Cypros Pharmaceutical Corp. | Health Technology |
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
EBD Group, Inc.
EBD Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Informa Plc, EBD Group, Inc. operates as a partnering company for the life science industry. The company is based in Carlsbad, CA. EBD Group was acquired by Informa Switzerland Ltd. on June 07, 2013. | Commercial Services |
| Glaxo, Inc. |